Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Fabio Barra, Carolina Scala, Valerio Mais, Stefano Guerriero & Simone Ferrero. (2018) Investigational drugs for the treatment of endometriosis, an update on recent developments. Expert Opinion on Investigational Drugs 27:5, pages 445-458.
Read now
Read now
Umberto Leone Roberti Maggiore & Simone Ferrero. (2016) An overview of early drug development for endometriosis. Expert Opinion on Investigational Drugs 25:2, pages 227-247.
Read now
Read now
R. A. Lobo, S. R. Davis, T. J. De Villiers, A. Gompel, V. W. Henderson, H. N. Hodis, M. A. Lumsden, W. J. Mack, S. Shapiro & R. J. Baber. (2014) Prevention of diseases after menopause. Climacteric 17:5, pages 540-556.
Read now
Read now
Sebastian Mirkin & James H Pickar. (2013) Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination. International Journal of Women's Health 5, pages 465-475.
Read now
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Read now
D. W. Sturdee & A. Pines. (2011) Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 14:3, pages 302-320.
Read now
Read now
Hisaya Kawate & Ryoichi Takayanagi. (2011) Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Clinical Interventions in Aging 6, pages 151-160.
Read now
Read now
Articles from other publishers (6)
Tobie J. de Villiers. (2023) Bone health and menopause: Osteoporosis prevention and treatment. Best Practice & Research Clinical Endocrinology & Metabolism, pages 101782.
Crossref
Crossref
Simona MARTONE, Libera TROÌA, Paola MARCOLONGO & Stefano LUISI. (2021) Role of medical treatment of endometriosis. Minerva Obstetrics and Gynecology 73:3.
Crossref
Crossref
Haiyan Ma, Dan Yan, Yina Wang, Wei Shi, Tianshu Liu, Chongqiang Zhao, Shengqi Huo, Jialin Duan, Jingwen Tao, Maocai Zhai, Pengcheng Luo, Junyi Guo, Lei Tian, Lulu Mageta, David Jou, Cuntai Zhang, Chenglong Li, Jiayuh Lin, Jiagao Lv, Sheng Li & Li Lin. (2019) Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Cancer Science 110:3, pages 950-961.
Crossref
Crossref
Santiago Palacios, Stuart L. Silverman, Tobie J. de Villiers, Amy B. Levine, Stefan Goemaere, Jacques P. Brown, Fiorenzo De Cicco Nardone, Robert Williams, Teresa L. Hines, Sebastian Mirkin & Arkadi A. Chines. (2015) A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis. Menopause 22:8, pages 806-813.
Crossref
Crossref
M. A. Arevalo, Y. Diz-Chaves, M. Santos-Galindo, M. J. Bellini & L. M. Garcia-Segura. (2012) Selective Oestrogen Receptor Modulators Decrease the Inflammatory Response of Glial Cells. Journal of Neuroendocrinology 24:1, pages 183-190.
Crossref
Crossref
Tobias Johannes de Villiers. (2011) Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence. Clinical Investigation 1:5, pages 719-724.
Crossref
Crossref